Literature DB >> 24115727

Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.

Andrew J Murphy1, Janene Pierce, Christian de Caestecker, Jaime Libes, David Neblett, Mark de Caestecker, Alan O Perantoni, Shunsuke Tanigawa, James R Anderson, Jeffrey S Dome, Amrita Das, Thomas J Carroll, Harold N Lovvorn.   

Abstract

BACKGROUND: The Yes-associated-protein-1 (YAP1) is a novel, direct regulator of stem cell genes both in development and cancer. FAT4 is an upstream regulator that induces YAP1 cytosolic sequestering by phosphorylation (p-Ser 127) and therefore inhibits YAP1-dependent cellular proliferation. We hypothesized that loss of FAT4 signaling would result in expansion of the nephron progenitor population in kidney development and that YAP1 subcellular localization would be dysregulated in Wilms tumor (WT), an embryonal malignancy that retains gene expression profiles and histologic features reminiscent of the embryonic kidney.
METHODS: Fetal kidneys from Fat4(-/-) mice were harvested at e18.5 and markers of nephron progenitors were investigated using immunohistochemical analysis. To examine YAP1 subcellular localization in WT, a primary WT cell line (VUWT30) was analyzed by immunofluorescence. Forty WT specimens evenly distributed between favorable and unfavorable histology (n = 20 each), and treatment failure or success (n = 20 each) was analyzed for total and phosphorylated YAP1 using immunohistochemistry and Western blot.
RESULTS: Fat4(-/-) mouse fetal kidneys exhibit nuclear YAP1 with increased proliferation and expansion of nephron progenitor cells. In contrast to kidney development, subcellular localization of YAP1 is dysregulated in WT, with a preponderance of nuclear p-YAP1. By Western blot, median p-YAP1 quantity was 5.2-fold greater in unfavorable histology WT (P = 0.05).
CONCLUSIONS: Fetal kidneys in Fat4(-/-) mice exhibit a phenotype reminiscent of nephrogenic rests, a WT precursor lesion. In WT, YAP1 subcellular localization is dysregulated and p-YAP1 accumulation is a novel biomarker of unfavorable histology.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wilms tumor; YAP1; anaplasia; biomarker; nephrogenic rests

Mesh:

Substances:

Year:  2013        PMID: 24115727      PMCID: PMC3955491          DOI: 10.1002/pbc.24788

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  32 in total

Review 1.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.

Authors:  Bin Zhao; Karen Tumaneng; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-08-01       Impact factor: 28.824

2.  Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.

Authors:  Wei Kang; Joanna H M Tong; Anthony W H Chan; Tin-Lap Lee; Raymond W M Lung; Patrick P S Leung; Ken K Y So; Kaichun Wu; Daiming Fan; Jun Yu; Joseph J Y Sung; Ka-Fai To
Journal:  Clin Cancer Res       Date:  2011-02-23       Impact factor: 12.531

Review 3.  Cancer stem cell niche: the place to be.

Authors:  Tijana Borovski; Felipe De Sousa E Melo; Louis Vermeulen; Jan Paul Medema
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

4.  A Smad action turnover switch operated by WW domain readers of a phosphoserine code.

Authors:  Eric Aragón; Nina Goerner; Alexia-Ileana Zaromytidou; Qiaoran Xi; Albert Escobedo; Joan Massagué; Maria J Macias
Journal:  Genes Dev       Date:  2011-06-15       Impact factor: 11.361

5.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

Authors:  Sergey I Nikolaev; Donata Rimoldi; Christian Iseli; Armand Valsesia; Daniel Robyr; Corinne Gehrig; Keith Harshman; Michel Guipponi; Olesya Bukach; Vincent Zoete; Olivier Michielin; Katja Muehlethaler; Daniel Speiser; Jacques S Beckmann; Ioannis Xenarios; Thanos D Halazonetis; C Victor Jongeneel; Brian J Stevenson; Stylianos E Antonarakis
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

6.  YAP is a candidate oncogene for esophageal squamous cell carcinoma.

Authors:  Tomoki Muramatsu; Issei Imoto; Takeshi Matsui; Ken-Ichi Kozaki; Shigeo Haruki; Marius Sudol; Yutaka Shimada; Hitoshi Tsuda; Tatsuyuki Kawano; Johji Inazawa
Journal:  Carcinogenesis       Date:  2010-11-26       Impact factor: 4.944

7.  Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1.

Authors:  Yaochen Li; Matthew Aaron Hibbs; Ashley Lauren Gard; Natalia Aliakseeuna Shylo; Kyuson Yun
Journal:  Stem Cells       Date:  2012-04       Impact factor: 6.277

8.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Authors:  Malcolm A Smith; Nita L Seibel; Sean F Altekruse; Lynn A G Ries; Danielle L Melbert; Maura O'Leary; Franklin O Smith; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544

9.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).

Authors:  Bin Zhao; Li Li; Karen Tumaneng; Cun-Yu Wang; Kun-Liang Guan
Journal:  Genes Dev       Date:  2010-01-01       Impact factor: 11.361

Review 10.  Wilms' tumor.

Authors:  Andrew M Davidoff
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

View more
  11 in total

Review 1.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

Review 2.  The nuclear lamina is mechano-responsive to ECM elasticity in mature tissue.

Authors:  Joe Swift; Dennis E Discher
Journal:  J Cell Sci       Date:  2014-06-24       Impact factor: 5.285

Review 3.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

4.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

5.  Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.

Authors:  Liangang Ma; Jianxin Cui; Hongqing Xi; Shibo Bian; Bo Wei; Lin Chen
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 6.  The yin and yang of kidney development and Wilms' tumors.

Authors:  Peter Hohenstein; Kathy Pritchard-Jones; Jocelyn Charlton
Journal:  Genes Dev       Date:  2015-03-01       Impact factor: 11.361

7.  FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.

Authors:  Rui Liu; Shan Huang; Yunlong Lei; Tao Zhang; Kui Wang; Bo Liu; Edouard C Nice; Rong Xiang; Ke Xie; Jingyi Li; Canhua Huang
Journal:  Oncotarget       Date:  2015-01-20

8.  Inhibitory mechanism of FAT4 gene expression in response to actin dynamics during Src-induced carcinogenesis.

Authors:  Takao Ito; Hiroaki Taniguchi; Kousuke Fukagai; Shota Okamuro; Akira Kobayashi
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

Review 9.  Mechanosensing by the nucleus: From pathways to scaling relationships.

Authors:  Sangkyun Cho; Jerome Irianto; Dennis E Discher
Journal:  J Cell Biol       Date:  2017-01-02       Impact factor: 10.539

10.  Single-cell analysis of progenitor cell dynamics and lineage specification in the human fetal kidney.

Authors:  Rajasree Menon; Edgar A Otto; Austin Kokoruda; Jian Zhou; Zidong Zhang; Euisik Yoon; Yu-Chih Chen; Olga Troyanskaya; Jason R Spence; Matthias Kretzler; Cristina Cebrián
Journal:  Development       Date:  2018-08-30       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.